Moderna Inc. MRNA announced Monday, July 11, that its omicron booster candidate has showed a stronger response against subvariants than its original shot.
On CNBC's "Options Action," Michael Khouw of Optimize Advisors said the Cambridge, Massachusetts-based company traded more than 1.6 times its average daily call volume on Monday.
Calls outpaced puts by 3:2, he added.
Check out other stocks making big moves in the premarket.
There was a buyer of 1,000 of the October 250 strike calls at an average price of $5.70 per contract, Khouw mentioned. The trader bet $570,000 for at least a 40% rise in Moderna’s stock by October expiration.
MRNA Price Action: Shares of Moderna have lost more than 25% year to date. The company opened Tuesday, July 12, at $175.41 per share.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
